Navigation Links
Good News For Those Of You Suffering From Rheumatoid Arthritis

Combination therapy with the new biologic drug adalimumab and methotrexate has been found to be about five times more effective for people with long-standing rheumatoid arthritis when compared to the usual management // with methotrexate alone. It has been found to decrease pain and swelling in patients who fail to respond to standard treatment.

At the end of the 6-month trial, 43 percent of all subjects on adalimumab plus methotrexate had achieved a 50-percent improvement in symptoms, compared with 9 percent of all subjects receiving placebo plus methotrexate. In addition, adalimumab injections slowed progression of joint damage as revealed by joint X-rays.

Rheumatoid arthritis is an autoimmune disease, which develops when certain cells of the immune system malfunction and attack healthy joints. The cause of rheumatoid arthritis is unknown. The primary focus of the inflammation is in the synovium, the lining tissue of the joint. Inflammatory chemicals released by the immune cells cause swelling and damage to cartilage and bone.

Adalimumab works by preventing a protein called tumor necrosis factor (TNF) from signaling the release of joint-damaging substances. Adalimumab is approved for the treatment of moderate to severe rheumatoid arthritis in adults who do not respond to other treatments.

Addressing future research priorities, long-term efficacy and safety studies are needed before this therapy can be put into clinical practice.


'"/>




Page: 1

Related medicine news :

1. Identifying Those At Risk For Diabetes
2. Identifying Those At Risk For Diabetes
3. Hope For Those With Pancreatic Cancer
4. Good News For Those Suffering From Excessive Sweating
5. Cell Implants May Help Those Who Suffer From Parkinsons
6. Firms Told To Employ Those With Aspergers Syndrome
7. Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease
8. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
9. Number of Allergic Anaphylaxis Episodes Are Far More Than Those Recorded
10. Korea: No Discrimination against Those with AIDS/HIV in the Workplace
11. Free Herceptin Treatment for Those Who Live Over the Welsh Border

Post Your Comments:
(Date:12/2/2009)...y comparing standard conservative therapy to a min... decompression for painful herniated disc revealed...hort run, only disc decompression kept patients pa...y, the first of its kind, were presented today at ...North America (RSNA). , Discs are sponge-like cu...
(Date:12/1/2009)... Housing Enables a Positive Lock and Environmental...esota (Vocus) -- Omnetics Connector Corporation, t...announced the addition of a threaded metal shell c...re the smallest Mil-Quality circulars available. ...while compressing an o-ring to provide a waterproo...
(Date:12/1/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Global In Vitro Diagnostics Market Analy...tlinker.com/p0166596/Global-In-Vitro-Diagnostics-M...lobal In Vitro Diagnostics Market Analysis and For..."Global In Vitro Diagnostics (IVD) Market Analysis...
(Date:12/1/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Emerging Clinical Trial Locations - Ind...d regulatory environment ,, http://www.repor...ions---India-Market-dynamics-and-the-changing-heal... the last decade pharmaceutical and biotechnology ...
(Date:12/1/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Peptic Ulcer Testing - A World Market I....com/p0164350/Peptic-Ulcer-Testing---A-World-Marke... of peptic ulcers in developing, and underdevelope.... The bacteria, helicobacter pylori (H. pylori), i...
Breaking Medicine News(10 mins):Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:Omnetics Announces Newest Addition to Nano Circular Family 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 14Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 15Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 16Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 17Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 18Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 19Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 20Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 21Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 2Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 3
...vative New Treatments, AMSTERDAM, December 14 Ki...ATIR has received approval for regulatory,classifi...Innovation Task,Force (ITF), a division of the Eur...for orphan drug designation with the EMEA,to obtai...
... Riversides Douglas Ethell , an assistant profess...lls die in disorders such as Alzheimers and Parkin...nt by the California Institute for Regenerative Me...yonic stem cells for treating Alzheimers disease, ...
... deal of welcome progress in the last several deca... obstructive pulmonary disease (COPD) is on the ri.... By 2000, the number of women dying from COPD sur..., The disease expression of COPD in women is diff...
...modern employment practices can put as much strain...tra 120 hours a year, an extensive study of the Br...Research Council suggests. , The research finds ... ways of extracting more effort and higher perform...
...rt of its ongoing,global campaign to lower drug pr...atments in India and worldwide, AIDS Healthcare Fo...ut recently offered in India by,generic drug manuf... pressuring Cipla to lower its prices in India --,...
... Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) anno...tion (FDA) has granted orphan drug status to ISIS ...myotrophic lateral sclerosis (ALS),commonly referr...611, a second-generation antisense drug, is Isis,f...
Other Medicine News:Health News:ATIR Classified as "Cell Based" Medicinal Product by the EMEA 2Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 2Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 3Health News:When disease discriminates: Women and COPD 2Health News:When disease discriminates: Women and COPD 3Health News:Workplace opportunities and stresses are both increasing 2Health News:Workplace opportunities and stresses are both increasing 3Health News:Workplace opportunities and stresses are both increasing 4Health News:Cipla Offers Modest AIDS Drug Price Cut: 'Not Nearly Enough,' says AHF 2Health News:Cipla Offers Modest AIDS Drug Price Cut: 'Not Nearly Enough,' says AHF 3Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 2Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 3
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Direct to Consumer (DTC) Advertising in Ph... Regulatory Landscape and Case Studies ,, htt...er-DTC-Advertising-in-Pharmaceuticals---Current-an...ase-Studies.html ,, Summary ,, The author...
(Date:12/1/2009)...wswire/ -- RoundTable Healthcare Partners, an oper...vely on the health-care industry, announced today ... sell one of its portfolio companies, Ascent Healt...("Stryker"), one of the world,s leading medical te...or to closing, Ascent will distribute $35 million ...
(Date:12/1/2009)...wswire/ -- CeloNova BioSciences, Inc., a provider ...s and of specialty implants, today announced that ...edical director of Baptist Cardiac & Vascular ...NIA(TM) Stent System with NanoThin Polyzene®-...ns Conference to be held at the Hotel David InterC...
Breaking Medicine Technology:Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation 2Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial 4970 1Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial 4970 2Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial 4970 3First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 1First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 2Columbia South Carolina Plastic Cosmetic Surgeon Gives his Website a State of the Art Lift 56897 1Columbia South Carolina Plastic Cosmetic Surgeon Gives his Website a State of the Art Lift 56897 2Columbia South Carolina Plastic Cosmetic Surgeon Gives his Website a State of the Art Lift 56897 3
...nd Significantly Improves Effectiveness of ...Mass., March 10 Thermo Fisher,Scientific Inc. (NY...as,developed a breakthrough gene-silencing tool th...hnology and eliminates barriers associated with,pr...xpected to accelerate,research and drug discovery ...
...al Meeting Support Longterm ... Genzyme Corp.,(Nasdaq: GENZ ), today announced ...tudy that investigated the long-term durability of... patients who had pain and,functional impairment f...ee. These findings revealed that almost 90 percent...
Other Medicine Technology:Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 2Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 3Genzyme Announces Presentation of New Positive Data on Carticel(R) 2Genzyme Announces Presentation of New Positive Data on Carticel(R) 3Genzyme Announces Presentation of New Positive Data on Carticel(R) 4Genzyme Announces Presentation of New Positive Data on Carticel(R) 5Genzyme Announces Presentation of New Positive Data on Carticel(R) 6
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: